RL

Rupali Laxmanrao Gadam

Active Director Director DIN 07063969
DIN 07063969 First appointment Mar 2015 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2015
Shareholding value •••• Premium profile

About Rupali Laxmanrao Gadam

Data last updated:

Rupali Laxmanrao Gadam is a Director at Rivoma Pharmaceuticals Private Limited (since 2015). The company operates in Trading. Rivoma Pharmaceuticals Private Limited reported revenue of ₹1.7 Lakh (FY 2025).

DIN 07063969
Primary Designation Director
Industry Trading
First Appointment 09 Mar 2015
Oldest Company Age 11 yrs
Largest company Rivoma Pharmaceuticals Private Limited · ₹1.7 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director09 Mar 20152015₹1.7 Lakh (FY 2025)Active

Board colleagues of Rupali Laxmanrao Gadam

NameDINCompanyDesignation
Rekha Vijay Uttarwar10624742Rivoma Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Rivoma Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rupali Laxmanrao Gadam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rupali Laxmanrao Gadam

Rupali Laxmanrao Gadam currently holds 1 directorship: Rivoma Pharmaceuticals Private Limited (Director, since 09 Mar 2015, revenue ₹1.7 Lakh (FY 2025)).

Rupali Laxmanrao Gadam was first appointed on 09 Mar 2015 as Director at Rivoma Pharmaceuticals Private Limited.

The current boards of Rupali Laxmanrao Gadam's companies include Rekha Vijay Uttarwar (Rivoma Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available